Physician profile
Bret E Heskett
NPI 1306054952
$3,480.24
in general payments reported to CMS, 2019-2025
19 companies · $256 in 2025
The $256 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $38.80 · 2021: $14.48 · 2022: $259 · 2023: $2,647 · 2024: $143 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $1,048 · Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $1,048.09 |
| Food and Beverage | $498.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,628.72 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Biogen, INC. | $160.09 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $101.14 | 2023-2024 | Myfembree |
| Abbvie INC. | $89.56 | 2020-2024 | |
| Millicent US INC | $51.47 | 2025 | Femlyv, Femring, Intrarosa |
| Medtronic, INC. | $46.82 | 2022-2024 | Truclear |
| Organon LLC | $46.04 | 2024-2025 | Nexplanon |
| Pfizer INC. | $44.39 | 2022-2023 | |
| Myovant Sciences INC. | $41.42 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.96 | 2019-2020 | |
| Minerva Surgical, INC | $36.33 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $35.45 | 2019 | |
| Novo Nordisk INC | $32.69 | 2019-2024 | Wegovy |
| Amarin Pharma, INC. | $26.62 | 2020-2021 | |
| Amgen INC. | $24.94 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $24.42 | 2025 | Exparel |
| Exeltis, USA INC. | $17.32 | 2023 | Slynd |
| Mayne Pharma Commercial LLC | $16.33 | 2022 | |
| Shire North American Group INC | $15.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Heskett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.